等待開盤 09-25 09:30:00 美东时间
-0.960
-2.11%
Apogee Therapeutics announced that its management team will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on September 16, 2025. The event will be available live and archived on the company’s website. Apogee is a biotech company focusing on developing novel biologics for large I&I markets, including treatments for Atopic Dermatitis, asthma, and other conditions.
09-03 11:30
American Woodmark (NASDAQ:AMWD) is preparing to release its quarterly earnings ...
08-25 23:01
Apogee ( ($APOG) ) has issued an update. On August 7, 2025, Apogee Enterprises ...
08-08 06:22
Apogee ( ($APOG) ) has provided an announcement. On June 25, 2025, Apogee held ...
07-07 22:27
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
Top Wall Street analysts changed their outlook on these top names. For a comple...
07-02 01:52
DA Davidson analyst Brent Thielman maintains Apogee Enterprises (NASDAQ:APOG) with a Neutral and lowers the price target from $47 to $45.
07-01 23:45
Apogee Enterprises ( ($APOG) ) has released its Q1 earnings. Here is a breakdow...
06-28 11:50
Apogee Enterprises (APOG) reported strong first-quarter fiscal 2025 results, with revenue up 4.6% and adjusted EPS of 56 cents, beating estimates. The company also raised its full-year outlook.
06-27 20:53
Fiscal 2026 OutlookThe Company is raising its outlook for the fiscal year for both net sales and diluted EPS. The Company now expects net sales in the range of $1.40 billion to $1.44 billion (previously $1.37 billion to
06-27 18:12
公司名稱
|
远地点企业公司
|
行業分類
|
建筑材料
|
業務描述
|
Apogee Enterprises, Inc. engages in the design and development of architectural products and services. It also provides architectural glass, aluminum framing systems and installation services for buildings, as well as value-added glazing products for custom picture framing. The company operates through the following segments: Architectural Framing Systems, Architectural Glass, Architectural Services, and Large-Scale Optical Technologies. The Architectural Framing Systems segment designs, engineers, fabricates and finishes aluminum window, curtainwall, storefront and entrance systems comprising the exterior of buildings. The Architectural Glass segment fabricates coated, glass used in custom window and wall systems. The Architectural Services segment integrates technical services, project management, and field installation services to design, engineer, fabricate, and install building glass and curtainwall systems. The Large-Scale Optical Technologies (LSO) segment manufactures value-added coated glass and acrylic products for custom framing, museum, and technical glass markets. The company was founded in 1949 and is headquartered in Minneapolis, MN.
|
Apogee Therapeutics announced that its management team will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on September 16, 2025. The event will be available live and archived on the company’s website. Apogee is a biotech company focusing on developing novel biologics for large I&I markets, including treatments for Atopic Dermatitis, asthma, and other conditions.
09-03 11:30
American Woodmark (NASDAQ:AMWD) is preparing to release its quarterly earnings ...
08-25 23:01
Apogee ( ($APOG) ) has issued an update. On August 7, 2025, Apogee Enterprises ...
08-08 06:22
Apogee ( ($APOG) ) has provided an announcement. On June 25, 2025, Apogee held ...
07-07 22:27
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
Top Wall Street analysts changed their outlook on these top names. For a comple...
07-02 01:52
DA Davidson analyst Brent Thielman maintains Apogee Enterprises (NASDAQ:APOG) with a Neutral and lowers the price target from $47 to $45.
07-01 23:45
Apogee Enterprises ( ($APOG) ) has released its Q1 earnings. Here is a breakdow...
06-28 11:50
Apogee Enterprises (APOG) reported strong first-quarter fiscal 2025 results, with revenue up 4.6% and adjusted EPS of 56 cents, beating estimates. The company also raised its full-year outlook.
06-27 20:53
Fiscal 2026 OutlookThe Company is raising its outlook for the fiscal year for both net sales and diluted EPS. The Company now expects net sales in the range of $1.40 billion to $1.44 billion (previously $1.37 billion to
06-27 18:12
派息除權日
|
每股總股息
| 派息日期 |
2025-07-16
|
0.26
|
2025-07-31
|
2025-05-13
|
0.26
|
2025-05-28
|
2025-01-28
|
0.26
|
2025-02-12
|
2024-10-22
|
0.25
|
2024-11-06
|
2024-07-10
|
0.25
|
2024-07-25
|
2024-05-20
|
0.25
|
2024-06-05
|
2024-01-29
|
0.25
|
2024-02-14
|
2023-10-23
|
0.24
|
2023-11-08
|
2023-07-11
|
0.24
|
2023-07-27
|
2023-05-08
|
0.24
|
2023-05-24
|
2023-01-30
|
0.24
|
2023-02-15
|
2022-10-24
|
0.22
|
2022-11-09
|
2022-07-11
|
0.22
|
2022-07-27
|
2022-05-09
|
0.22
|
2022-05-25
|
2022-01-28
|
0.22
|
2022-02-15
|
2021-10-25
|
0.20
|
2021-11-10
|
2021-07-13
|
0.20
|
2021-07-29
|
2021-05-07
|
0.20
|
2021-05-25
|
2021-01-29
|
0.20
|
2021-02-16
|
2020-10-23
|
0.19
|
2020-11-10
|
2020-07-13
|
0.19
|
2020-07-29
|
2020-05-13
|
0.19
|
2020-05-29
|
2020-01-31
|
0.19
|
2020-02-18
|
2019-10-18
|
0.17
|
2019-11-05
|
2019-07-15
|
0.17
|
2019-07-31
|
2019-05-15
|
0.17
|
2019-05-31
|
2019-02-04
|
0.17
|
2019-02-20
|
2018-10-22
|
0.16
|
2018-11-07
|
2018-07-17
|
0.16
|
2018-08-02
|
2018-05-15
|
0.16
|
2018-05-31
|
2018-01-29
|
0.16
|
2018-02-14
|
2017-10-23
|
0.14
|
2017-11-08
|
2017-07-06
|
0.14
|
2017-07-25
|
2017-05-17
|
0.14
|
2017-06-02
|
2017-01-27
|
0.14
|
2017-02-15
|
2016-10-21
|
0.13
|
2016-11-09
|
2016-07-08
|
0.13
|
2016-07-27
|
2016-05-10
|
0.13
|
2016-05-27
|
2016-01-29
|
0.13
|
2016-02-17
|
2015-10-23
|
0.11
|
2015-11-10
|
2015-07-13
|
0.11
|
2015-07-30
|
2015-05-15
|
0.11
|
2015-05-29
|
2015-02-03
|
0.11
|
2015-02-19
|
2014-10-24
|
0.10
|
2014-11-12
|
2014-07-11
|
0.10
|
2014-07-30
|
2014-05-16
|
0.10
|
2014-05-30
|
2014-02-04
|
0.10
|
2014-02-21
|
2013-10-25
|
0.09
|
2013-11-13
|
2013-07-12
|
0.09
|
2013-07-31
|
2013-05-17
|
0.09
|
2013-05-31
|
2013-02-05
|
0.09
|
2013-02-22
|
2012-10-26
|
0.09
|
2012-11-14
|
2012-07-09
|
0.09
|
2012-07-26
|
2012-05-15
|
0.09
|
2012-06-01
|
2012-02-03
|
0.08
|
2012-02-22
|
2011-10-20
|
0.08
|
2011-11-08
|
2011-07-08
|
0.08
|
2011-07-27
|
2011-05-13
|
0.08
|
2011-06-01
|
2011-02-04
|
0.08
|
2011-02-23
|
2010-10-22
|
0.08
|
2010-11-10
|
2010-07-09
|
0.08
|
2010-07-28
|
2010-05-14
|
0.08
|
2010-06-02
|
2010-02-05
|
0.08
|
2010-02-24
|
2009-10-23
|
0.08
|
2009-11-12
|
2009-07-10
|
0.08
|
2009-07-29
|
2009-05-15
|
0.08
|
2009-06-03
|
2009-02-06
|
0.08
|
2009-02-25
|
2008-10-24
|
0.08
|
2008-11-12
|
2008-07-11
|
0.07
|
2008-07-30
|
2008-05-16
|
0.07
|
2008-06-04
|
2008-02-08
|
0.07
|
2008-02-27
|
2007-10-26
|
0.07
|
2007-11-14
|
2007-07-13
|
0.07
|
2007-07-31
|
2007-05-18
|
0.07
|
2007-06-06
|
2007-02-09
|
0.07
|
2007-02-28
|
2006-10-27
|
0.07
|
2006-11-15
|
2006-07-14
|
0.06
|
2006-08-02
|
2006-05-12
|
0.06
|
2006-05-31
|
2006-02-09
|
0.06
|
2006-03-01
|
2005-11-03
|
0.06
|
2005-11-21
|
2005-07-07
|
0.06
|
2005-07-27
|
2005-04-28
|
0.06
|
2005-05-18
|
2005-02-10
|
0.06
|
2005-03-02
|
2004-10-25
|
0.06
|
2004-11-10
|
2004-08-05
|
0.06
|
2004-08-18
|
2004-05-03
|
0.06
|
2004-05-19
|
2004-01-30
|
0.06
|
2004-02-18
|
2003-10-27
|
0.06
|
2003-11-12
|
2003-08-07
|
0.06
|
2003-08-26
|
2003-04-25
|
0.06
|
2003-05-14
|
2003-01-30
|
0.06
|
2003-02-19
|
2002-10-24
|
0.06
|
2002-11-13
|
2002-08-08
|
0.05
|
2002-08-28
|
2002-04-25
|
0.05
|
2002-05-15
|
2002-01-31
|
0.05
|
2002-02-20
|
2001-10-25
|
0.05
|
2001-11-14
|
2001-08-09
|
0.05
|
2001-08-29
|
2001-04-26
|
0.05
|
2001-05-16
|
2001-02-01
|
0.05
|
2001-02-21
|
2000-10-26
|
0.05
|
2000-11-15
|
2000-08-10
|
0.05
|
2000-08-30
|
2000-04-27
|
0.05
|
2000-05-17
|
2000-01-27
|
0.05
|
2000-02-16
|
1999-10-21
|
0.05
|
1999-11-09
|
1999-08-12
|
0.05
|
1999-08-31
|
1999-04-29
|
0.05
|
1999-05-18
|
1999-01-22
|
0.05
|
1999-02-11
|
1998-10-23
|
0.05
|
1998-11-11
|
1998-08-07
|
0.05
|
1998-08-26
|
1998-05-01
|
0.05
|
1998-05-20
|
1998-01-23
|
0.05
|
1998-02-11
|
1997-10-24
|
0.05
|
1997-11-12
|
1997-08-08
|
0.05
|
1997-08-27
|
1997-05-02
|
0.05
|
1997-05-21
|
1997-01-24
|
0.09
|
1997-02-12
|
1996-10-25
|
0.09
|
1996-11-14
|
1996-08-09
|
0.09
|
1996-08-29
|
1996-05-03
|
0.09
|
1996-05-23
|
1996-01-26
|
0.09
|
1996-02-15
|
1995-10-27
|
0.09
|
1995-11-16
|
1995-08-11
|
0.08
|
1995-08-31
|
1995-05-03
|
0.08
|
1995-05-25
|
1995-01-25
|
0.08
|
1995-02-16
|
1994-10-26
|
0.08
|
1994-11-17
|
1994-08-10
|
0.08
|
1994-09-01
|
1994-05-04
|
0.08
|
1994-05-26
|
1994-01-26
|
0.08
|
1994-02-17
|
1993-10-27
|
0.08
|
1993-11-18
|
1993-08-03
|
0.07
|
1993-08-25
|
1993-05-04
|
0.07
|
1993-05-26
|
1993-01-26
|
0.07
|
1993-02-18
|
1992-10-27
|
0.07
|
1992-11-19
|
1992-08-04
|
0.06
|
1992-08-27
|
1992-05-05
|
0.06
|
1992-05-29
|
1992-01-28
|
0.06
|
1992-02-20
|
1991-10-29
|
0.06
|
1991-11-20
|
1991-08-06
|
0.06
|
1991-08-28
|
1991-05-07
|
0.06
|
1991-05-30
|
1991-01-30
|
0.06
|
1991-02-21
|
1990-10-31
|
0.06
|
1990-11-21
|
1990-08-08
|
0.06
|
1990-08-29
|
1990-05-02
|
0.06
|
1990-05-23
|
1990-01-29
|
0.05
|
1990-02-15
|
1989-11-01
|
0.05
|
1989-11-16
|
1989-08-07
|
0.05
|
1989-08-29
|
1989-05-01
|
0.05
|
1989-05-23
|
1989-01-30
|
0.04
|
1989-02-16
|
1988-10-31
|
0.04
|
1988-11-16
|
1988-08-08
|
0.04
|
1988-08-24
|
1988-05-09
|
0.04
|
1988-05-26
|
1988-02-03
|
0.04
|
1988-02-25
|
1987-11-04
|
0.04
|
1987-11-24
|
1987-08-10
|
0.04
|
1987-08-28
|
1987-05-04
|
0.03
|
1987-05-22
|
1987-02-03
|
0.03
|
1987-02-23
|
1986-11-04
|
0.03
|
1986-11-25
|
1986-07-31
|
0.04
|
1986-08-20
|
1986-04-28
|
0.04
|
1986-05-16
|
1986-02-03
|
0.04
|
1986-02-19
|
1985-11-06
|
0.04
|
1985-11-22
|
1985-08-01
|
0.04
|
1985-08-22
|
1985-04-30
|
0.03
|
1985-05-17
|
1985-02-04
|
0.03
|
1985-02-21
|
1984-10-31
|
0.03
|
1984-11-23
|
1984-08-01
|
0.03
|
1984-08-17
|
1984-05-04
|
0.03
|
1984-05-23
|
1984-01-30
|
0.03
|
1984-02-17
|
1983-11-01
|
0.04
|
1983-11-18
|
1983-08-01
|
0.04
|
1983-08-19
|
1983-05-11
|
0.03
|
1983-05-27
|
1983-02-03
|
0.03
|
1983-02-25
|
1982-11-03
|
0.04
|
1982-11-26
|
1982-08-02
|
0.04
|
1982-08-20
|
1982-05-03
|
0.03
|
1982-05-21
|
1982-02-04
|
0.03
|
1982-02-26
|
1981-11-02
|
0.04
|
1981-11-23
|
1981-08-05
|
0.04
|
1981-08-28
|
1981-04-29
|
0.04
|
1981-05-22
|
1981-02-05
|
0.03
|
1981-02-27
|
1980-11-25
|
0.25
|
1980-11-24
|
1980-10-31
|
0.03
|
1980-11-24
|
1980-08-06
|
0.03
|
1980-08-29
|
1980-05-01
|
0.03
|
1980-05-23
|
1980-02-05
|
0.03
|
1980-02-28
|
1979-10-29
|
0.03
|
1979-11-25
|
1979-08-01
|
0.03
|
1979-08-23
|
1979-05-02
|
0.03
|
1979-05-24
|
1979-02-05
|
0.03
|
1979-03-01
|
1978-10-30
|
0.03
|
1978-11-26
|
1978-07-25
|
0.03
|
1978-08-20
|
1978-05-03
|
0.03
|
1978-05-29
|
1978-02-01
|
0.03
|
1978-02-23
|
1977-11-02
|
0.03
|
1977-11-29
|
1977-08-02
|
0.04
|
1977-08-21
|
1977-05-10
|
0.04
|
1977-05-29
|